Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

(MedPage Today) — SAN FRANCISCO — An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended treatment benefit versus transarterial chemoembolization (TACE), according to an interim analysis…

Source link : https://www.medpagetoday.com/meetingcoverage/mgics/119373

Author :

Publish date : 2026-01-10 20:15:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Immuno-Oncology Tops Embolization for Intermediate-Grade Liver Cancer

Global Pain Levels; Tertiary Patents on FDA-Approved Drugs

What Do the New Dietary Guidelines Emphasize?

Related Posts

Dream Orgasms: Clinical Insight or Emerging Phenomenon?

Rural Accountable Care Organizations: Better Diabetes Care

FDA Expert Panels Raise Legal, Credibility Questions

Studies Calculate Climate Change as a Health Danger. Trump Calls It a ‘Scam.’

EU Withdrawal of Levamisole Recommended Due to CNS Risks

Critical incident declared at Nottingham hospitals

Dream Orgasms: Clinical Insight or Emerging Phenomenon?

Rural Accountable Care Organizations: Better Diabetes Care

FDA Expert Panels Raise Legal, Credibility Questions

Studies Calculate Climate Change as a Health Danger. Trump Calls It a ‘Scam.’

EU Withdrawal of Levamisole Recommended Due to CNS Risks

Critical incident declared at Nottingham hospitals

FDA Leader Accused of Sexual Harassment; RFK Jr.’s Toilet Comment; GLP-1s and Scurvy

High Court dismisses challenge to single-sex toilet guidance

Categories

Archives